eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Allergan Ltd
Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Telephone: +44 (0)1628 494444
Fax: +44 (0)1628 494449
WWW: http://www.allergan.co.uk
Medical Information Direct Line: +44 (0)1628 494026
Medical Information e-mail: UK_MedInfo@Allergan.com
Out of Hours contact: +44 (0)1628 494026

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 25/07/2011
PIL Lumigan 0.3mg/ml eye drops, solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 06/05/2011 and displayed until 25/07/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 18/01/2010 and displayed until 06/05/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 24/09/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 03/11/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 27/09/2007 and displayed until 03/11/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 02/08/2007 and displayed until 27/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 14/12/2005 and displayed until 02/08/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 10/02/2004 and displayed until 14/12/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 13/05/2003 and displayed until 10/02/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  bimatoprost